We have previously reported an array comparative genomic hybridization profile that identifies triple-negative breast cancers (TNBC), with BRCA1 dysfunction (PMID: 22357256) BRCA1-like status was assessed in 101 patients with early-stage TNBC receiving adjuvant cyclophosphamide-based chemotherapy.
(PMID: 22357256) Sixty-six tumors (65%) had a BRCA1-like profile.
(PMID: 22357256).
